4//SEC Filing
van Houte Hans 4
Accession 0001817217-25-000005
CIK 0001549595other
Filed
Nov 2, 7:00 PM ET
Accepted
Nov 3, 7:14 PM ET
Size
5.4 KB
Accession
0001817217-25-000005
Insider Transaction Report
Form 4
van Houte Hans
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-11-03$12.56/sh−6,284$78,931→ 37,592 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- [F2]Represents the weighted average sale price. The lowest price at which shares were sold was $12.32 and the highest price at which shares were sold was $13.14. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
Documents
Issuer
Nurix Therapeutics, Inc.
CIK 0001549595
Entity typeother
Related Parties
1- filerCIK 0001817217
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 7:00 PM ET
- Accepted
- Nov 3, 7:14 PM ET
- Size
- 5.4 KB